Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

Company's HIV-resistance Test Receives Approval from FDA


Seattle Post-Intelligencer (09.27.01) - Thursday, September

Visible Genetics, Inc. said yesterday that the FDA had approved its genetic test for HIV resistance. The TruGene test is the first agency-approved test for analyzing weaknesses in a patient's strain of HIV. It can help doctors pick the AIDS drugs that are likely to be the most effective against the virus.


Copyright © 2001 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in September 27, 2001. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.